Ureteral Orifice Stricture After Transurethral Resection of Bladder Tumors Involving the Ureteral Orifice or Adjacent Area: Clinical Course and Outcomes

BACKGROUND/AIM: Ureteral orifice stricture after transurethral resection of bladder tumor (TURBT) involving the ureteral orifice or adjacent area has not been sufficiently characterized. This study investigated the incidence, associated factors, management, and outcomes of this unique clinical entity. PATIENTS AND METHODS: We retrospectively analyzed 60 patients who underwent TURBT around the ureteral orifice, including the ureteral orifice itself, between January 2023 and September 2025. Those with a history of ureteral orifice stricture, ureteral orifice recurrence after upper tract urothelial carcinoma, and prior ureterocutaneostomy, as well as patients who did not undergo postoperative stent removal were excluded. Ureteral orifice stricture was defined as hydronephrosis or ureteral orifice obstruction after TURBT requiring clinical intervention, or cases associated with flank pain or deterioration of renal function. RESULTS: Ureteral orifice stricture developed in eight patients (13.3%). The median time to detection was 4.2 months. No statistically significant factors associated with ureteral orifice stricture were identified. All patients with a stricture required additional intervention. Management included transurethral resection of the stricture followed by double-J stent placement in three patients, double-J stent placement alone in two, double-J stent placement after nephrostomy in two, and transurethral resection of the stricture alone in one. At last follow-up, five patients were stent free, two required stent exchange, and one developed recurrent stricture but did not wish to undergo repeat stent placement because of stent-related bladder irritation. CONCLUSION: Ureteral orifice stricture after TURBT involving the ureteral orifice or adjacent area occurred at a non-negligible rate and was usually detected within several months after surgery. Although definitive associated factors were not identified, all patients who developed ureteral orifice stricture required additional intervention, suggesting that this complication can impose a substantial clinical burden. Careful postoperative surveillance and individualized management are warranted.

Authors

Institutions

Publication Details

Journal
In Vivo
Published
2026-06-30
DOI
https://doi.org/10.21873/invivo.14385
Primary Topic
Bladder and Urothelial Cancer Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ureteral Orifice Stricture After Transurethral Resection of Bladder Tumors Involving the Ureteral Orifice or Adjacent Area: Clinical Course and Outcomes

Takahito Negishi, Yuta Shiraishi, Azusa Takayama, Nobuki Furubayashi et al.
In Vivo
Bladder and Urothelial Cancer Treatments
article

Ureteral Orifice Stricture After Transurethral Resection of Bladder Tumors Involving the Ureteral Orifice or Adjacent Area: Clinical Course and Outcomes

Takahito Negishi, Yuta Shiraishi, Azusa Takayama, Nobuki Furubayashi, Motonobu Nakamura, Takehito Kojima, JIRO TSUJITA, YASUHIRO NAKANO, AKARI KATAOKA
article en

Abstract

BACKGROUND/AIM: Ureteral orifice stricture after transurethral resection of bladder tumor (TURBT) involving the ureteral orifice or adjacent area has not been sufficiently characterized. This study investigated the incidence, associated factors, management, and outcomes of this unique clinical entity. PATIENTS AND METHODS: We retrospectively analyzed 60 patients who underwent TURBT around the ureteral orifice, including the ureteral orifice itself, between January 2023 and September 2025. Those with a history of ureteral orifice stricture, ureteral orifice recurrence after upper tract urothelial carcinoma, and prior ureterocutaneostomy, as well as patients who did not undergo postoperative stent removal were excluded. Ureteral orifice stricture was defined as hydronephrosis or ureteral orifice obstruction after TURBT requiring clinical intervention, or cases associated with flank pain or deterioration of renal function. RESULTS: Ureteral orifice stricture developed in eight patients (13.3%). The median time to detection was 4.2 months. No statistically significant factors associated with ureteral orifice stricture were identified. All patients with a stricture required additional intervention. Management included transurethral resection of the stricture followed by double-J stent placement in three patients, double-J stent placement alone in two, double-J stent placement after nephrostomy in two, and transurethral resection of the stricture alone in one. At last follow-up, five patients were stent free, two required stent exchange, and one developed recurrent stricture but did not wish to undergo repeat stent placement because of stent-related bladder irritation. CONCLUSION: Ureteral orifice stricture after TURBT involving the ureteral orifice or adjacent area occurred at a non-negligible rate and was usually detected within several months after surgery. Although definitive associated factors were not identified, all patients who developed ureteral orifice stricture required additional intervention, suggesting that this complication can impose a substantial clinical burden. Careful postoperative surveillance and individualized management are warranted.

In VivoVol. 40(4)
National Hospital Organization Kyushu Cancer Center (JP)
Zero hunger
Openalex Percentile: Top 6%
Bladder and Urothelial Cancer Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.